IDXX
IDEXX LABORATORIES INC /DE
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$692.68
+3.07%Next report
Analyst consensus
- Next report date
- Feb 1, 2027
- EPS estimate
- $3.36
- Revenue estimate
- $1.2B
Latest reported
- Last report date
- Nov 2, 2026
- EPS actual
- $3.96
- EPS estimate
- $3.73
- Revenue actual
- $1.2B
- Revenue estimate
- $1.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 12
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +5.4%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $728
- PT range
- $670 – $810
- Analysts
- 6
3 Buy3 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 2, 2026 | $3.73 | $3.96 | Beat 6.17% | $1.2B |
| Aug 4, 2026 | $3.94 | $4.27 | Beat 8.38% | $1.2B |
| May 5, 2026 | $3.41 | $3.47 | Beat 1.76% | $1.1B |
| Feb 2, 2026 | $2.93 | $3.08 | Beat 5.12% | $1.1B |
| May 1, 2025 | $2.85 | $2.96 | Beat 3.86% | $998.4M |
| Feb 3, 2025 | $2.39 | $2.62 | Beat 9.62% | $954.3M |
| Oct 31, 2024 | $2.68 | $2.80 | Beat 4.48% | $975.5M |
| May 1, 2024 | $2.67 | $2.81 | Beat 5.24% | $964.1M |
| Nov 1, 2023 | $2.37 | $2.53 | Beat 6.75% | $915.5M |
| May 2, 2023 | $2.41 | $2.55 | Beat 5.63% | $900.2M |
| Feb 6, 2023 | $1.94 | $2.05 | Beat 5.94% | $828.6M |
| Nov 1, 2022 | $2.04 | $2.15 | Beat 5.55% | $841.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 1, 2027